| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.04. | Celyad Oncology SA reports FY results | 2 | Seeking Alpha | ||
| 04.04. | Celyad Oncology SA: Celyad Oncology Reports Full Year 2023 Financial Results and Recent Business Highlights | 396 | Business Wire | Regulatory News:
Celyad Oncology (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (the "Company"), today announces its financial results for the fiscal year 2023 ended December 31, 2023, and provides... ► Artikel lesen | |
| 04.04. | Celyad Oncology Reports Full Year 2023 Financial Results and Recent Business Highlights | 82 | Business Wire | MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Regulatory News:
Celyad Oncology (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (the "Company"), today announces its financial results for the fiscal... ► Artikel lesen | |
| 08.02. | Celyad Oncology SA: Celyad Oncology Announces Intention to Terminate SEC Reporting Obligations | 331 | Business Wire | Regulatory News:
Celyad Oncology SA (Euronext: CYAD) ("Celyad Oncology" or the "Company") announces that it will voluntarily file a Form 15F with the United States Securities and Exchange Commission... ► Artikel lesen | |
| 17.01. | Celyad Oncology SA - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 16.01. | Celyad Oncology Provides Fourth Quarter 2023 Business Update and 2024 Outlook | 376 | Business Wire | Three main pillars to unlock the potential of proprietary technology platforms and intellectual property:
A proprietary non-gene editing technology platform based on multiplexing of short hairpin... ► Artikel lesen | |
| 16.01. | Celyad Oncology SA: Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook | 277 | GlobeNewswire (Europe) | Three main pillars to unlock the potential of proprietary technology platforms and intellectual property: A proprietary non-gene editing technology platform based on multiplexing of short hairpin... ► Artikel lesen | |
| 20.12.23 | Celyad Oncology SA: Publication of a Transparency Notification Received From Fortress Investment Group LLC | 434 | Business Wire | (Article 14 §1 of the Law of 2 May 2007)
Regulatory News:
Celyad Oncology SA (Euronext: CYAD) ("Celyad Oncology" or the "Company") (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) today announces... ► Artikel lesen | |
| 18.12.23 | Celyad Oncology SA - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 15.12.23 | Celyad Oncology SA: Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007) | 488 | Business Wire | Regulatory News:
Celyad Oncology (Euronext: CYAD) (the "Company" or "Celyad Oncology"), today announces that 6,500,000 shares of CFIP CLYD (UK) Limited benefit from a double voting right as of... ► Artikel lesen | |
| 15.12.23 | Celyad Oncology SA: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007) | 3 | GlobeNewswire (USA) | ||
| 04.12.23 | Celyad Oncology SA - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 04.12.23 | Celyad Oncology SA: Celyad Announces Management Change | 302 | Business Wire | Regulatory News:
Celyad Oncology (Euronext: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a cutting-edge biotechnology company dedicated to pioneering the discovery and advancement of revolutionary... ► Artikel lesen | |
| 30.11.23 | Celyad Oncology SA: Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007) | 366 | Business Wire | Regulatory News:
Celyad Oncology SA (Euronext: CYAD) ("Celyad Oncology" or the "Company") today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication... ► Artikel lesen | |
| 24.11.23 | Celyad Oncology SA - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 21.11.23 | Celyad Oncology SA: Publication of a transparency notification received from Fortress Investment Group LLC | 412 | Business Wire | (Article 14 §1 of the Law of 2 May 2007)
Regulatory News:
Celyad Oncology SA (Euronext: CYAD) ("Celyad Oncology" or the "Company") today announced, in accordance with Article 14 of the Belgian... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| PLUG POWER | 3.494 |
| GAMESTOP | 3.381 |
| EVOTEC | 3.154 |
| BAYER | 2.764 |
| NEL | 2.642 |
| TUI | 2.390 |
| AMC ENTERTAINMENT | 2.292 |
| RHEINMETALL | 1.844 |
| ALIBABA | 1.342 |
| NORDEX | 1.189 |
| DELIVERY HERO | 1.089 |
| MERCEDES-BENZ | 956 |
| NVIDIA | 930 |
| SIEMENS ENERGY | 923 |
| BYD | 920 |
| AIXTRON SE | 819 |
| DEUTSCHE PFANDBRIEFBANK | 735 |
| NOVAVAX | 698 |
| DEUTSCHE BANK | 681 |
| COMMERZBANK | 662 |
| VOLKSWAGEN | 657 |
| RWE | 655 |
| TESLA | 642 |
| ALLIANZ | 611 |
| PALANTIR TECHNOLOGIES | 578 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
